BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18537688)

  • 1. Recent advances in liver X receptor biology and chemistry.
    Goodwin BJ; Zuercher WJ; Collins JL
    Curr Top Med Chem; 2008; 8(9):781-91. PubMed ID: 18537688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic opportunities for liver X receptor modulators.
    Collins JL
    Curr Opin Drug Discov Devel; 2004 Sep; 7(5):692-702. PubMed ID: 15503871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological role of liver X receptors.
    Baranowski M
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 7():31-55. PubMed ID: 19258656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, structure activity relationships and X-Ray co-crystallography of non-steroidal LXR agonists.
    Bennett DJ; Carswell EL; Cooke AJ; Edwards AS; Nimz O
    Curr Med Chem; 2008; 15(2):195-209. PubMed ID: 18220775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver x receptors: potential novel targets in cardiovascular diseases.
    Bruemmer D; Law RE
    Curr Drug Targets Cardiovasc Haematol Disord; 2005 Dec; 5(6):533-40. PubMed ID: 16503873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver x receptor agonists inhibit cytokine-induced osteopontin expression in macrophages through interference with activator protein-1 signaling pathways.
    Ogawa D; Stone JF; Takata Y; Blaschke F; Chu VH; Towler DA; Law RE; Hsueh WA; Bruemmer D
    Circ Res; 2005 Apr; 96(7):e59-67. PubMed ID: 15790955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver X receptors as therapeutic targets in metabolism and atherosclerosis.
    Nomiyama T; Bruemmer D
    Curr Atheroscler Rep; 2008 Feb; 10(1):88-95. PubMed ID: 18366990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orphan nuclear receptors, PXR and LXR: new ligands and therapeutic potential.
    Gong H; Xie W
    Expert Opin Ther Targets; 2004 Feb; 8(1):49-54. PubMed ID: 14996618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nuclear receptor LXR is a glucose sensor.
    Mitro N; Mak PA; Vargas L; Godio C; Hampton E; Molteni V; Kreusch A; Saez E
    Nature; 2007 Jan; 445(7124):219-23. PubMed ID: 17187055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacology of LXR.
    Michael LF; Schkeryantz JM; Burris TP
    Mini Rev Med Chem; 2005 Aug; 5(8):729-40. PubMed ID: 16101409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear localization of liver X receptor alpha and beta is differentially regulated.
    Prüfer K; Boudreaux J
    J Cell Biochem; 2007 Jan; 100(1):69-85. PubMed ID: 16888799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The liver X receptors.
    Lala DS
    Curr Opin Investig Drugs; 2005 Sep; 6(9):934-43. PubMed ID: 16187693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver X receptors (LXRs). Part I: structure, function, regulation of activity, and role in lipid metabolism.
    Wójcicka G; Jamroz-Wiśniewska A; Horoszewicz K; Bełtowski J
    Postepy Hig Med Dosw (Online); 2007 Dec; 61():736-59. PubMed ID: 18063918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the AF-2 region abolish ligand-induced intranuclear immobilization of the liver X receptor alpha.
    Prüfer K; Hernandez C; Gilbreath M
    Exp Cell Res; 2008 Aug; 314(14):2652-60. PubMed ID: 18599038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver X receptor modulators: effects on lipid metabolism and potential use in the treatment of atherosclerosis.
    Fiévet C; Staels B
    Biochem Pharmacol; 2009 Apr; 77(8):1316-27. PubMed ID: 19101522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of liver X receptor agonist treatment on pulmonary inflammation and host defense.
    Smoak K; Madenspacher J; Jeyaseelan S; Williams B; Dixon D; Poch KR; Nick JA; Worthen GS; Fessler MB
    J Immunol; 2008 Mar; 180(5):3305-12. PubMed ID: 18292555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of liver X receptors promotes neuroprotection and reduces brain inflammation in experimental stroke.
    Morales JR; Ballesteros I; Deniz JM; Hurtado O; Vivancos J; Nombela F; Lizasoain I; Castrillo A; Moro MA
    Circulation; 2008 Sep; 118(14):1450-9. PubMed ID: 18794391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver X receptors as integrators of metabolic and inflammatory signaling.
    Zelcer N; Tontonoz P
    J Clin Invest; 2006 Mar; 116(3):607-14. PubMed ID: 16511593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver X receptors (LXRs). Part II: non-lipid effects, role in pathology, and therapeutic implications.
    Jamroz-Wiśniewska A; Wójcicka G; Horoszewicz K; Bełtowski J
    Postepy Hig Med Dosw (Online); 2007 Dec; 61():760-85. PubMed ID: 18063919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of liver X receptor signaling as novel therapy for prostate cancer.
    Chuu CP; Kokontis JM; Hiipakka RA; Liao S
    J Biomed Sci; 2007 Sep; 14(5):543-53. PubMed ID: 17372849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.